- 2024-09-23Procedural onlyproceduralApplication RoP262.1 (b)
The Paris Central Division (Seat) ruled on a third-party access application (R. 262.1(b) RoP) by KIPA AB (an anonymised applicant) seeking access to all pleadings and evidence in the revocation action between Meril entities and Edwards Lifesciences Corporation concerning EP 4 151 181. The court assessed the applicant's interest as a competitor investor in cardiac implant technology.